These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 9876341)
1. The impact of obesity on cardiovascular risk factors in Turner's syndrome. Elsheikh M; Conway GS Clin Endocrinol (Oxf); 1998 Oct; 49(4):447-50. PubMed ID: 9876341 [TBL] [Abstract][Full Text] [Related]
2. Lp(a) and lipids in adult Turner's syndrome: impact of treatment with 17beta-estradiol and norethisterone. Gravholt CH; Christian Klausen I; Weeke J; Sandahl Christiansen J Atherosclerosis; 2000 May; 150(1):201-8. PubMed ID: 10781652 [TBL] [Abstract][Full Text] [Related]
3. Glucose metabolism, lipid metabolism, and cardiovascular risk factors in adult Turner's syndrome. The impact of sex hormone replacement. Gravholt CH; Naeraa RW; Nyholm B; Gerdes LU; Christiansen E; Schmitz O; Christiansen JS Diabetes Care; 1998 Jul; 21(7):1062-70. PubMed ID: 9653596 [TBL] [Abstract][Full Text] [Related]
4. Adrenocorticotrophin stimulation and HLA polymorphisms suggest a high frequency of heterozygosity for steroid 21-hydroxylase deficiency in patients with Turner's syndrome and their families. Larizza D; Cuccia M; Martinetti M; Maghnie M; Dondi E; Salvaneschi L; Severi F Clin Endocrinol (Oxf); 1994 Jan; 40(1):39-45. PubMed ID: 8306479 [TBL] [Abstract][Full Text] [Related]
5. Effect of obesity on endogenous secretion of growth hormone in Turner's syndrome. Lu PW; Cowell CT; Jimenez M; Simpson JM; Silink M Arch Dis Child; 1991 Oct; 66(10):1184-90. PubMed ID: 1953000 [TBL] [Abstract][Full Text] [Related]
6. Aortic distensibility and dilation in Turner's syndrome. Sharma J; Friedman D; Dave-Sharma S; Harbison M Cardiol Young; 2009 Dec; 19(6):568-72. PubMed ID: 19857368 [TBL] [Abstract][Full Text] [Related]
7. Hypertension is a major risk factor for aortic root dilatation in women with Turner's syndrome. Elsheikh M; Casadei B; Conway GS; Wass JA Clin Endocrinol (Oxf); 2001 Jan; 54(1):69-73. PubMed ID: 11167928 [TBL] [Abstract][Full Text] [Related]
8. Serum lipids, lipoprotein lp(a), and plasminogen activator inhibitor-1 in patients with Turner's syndrome before and during growth hormone and estrogen therapy. Lanes R; Gunczler P; Palacios A; Villaroel O Fertil Steril; 1997 Sep; 68(3):473-7. PubMed ID: 9314917 [TBL] [Abstract][Full Text] [Related]
9. Normal bone density of the wrist and spine and increased wrist fractures in girls with Turner's syndrome. Ross JL; Long LM; Feuillan P; Cassorla F; Cutler GB J Clin Endocrinol Metab; 1991 Aug; 73(2):355-9. PubMed ID: 1856266 [TBL] [Abstract][Full Text] [Related]
11. [The values of peripheral blood cell count parameters in women with Turner's syndrome]. Jez W; Irzyniec T Pol Merkur Lekarski; 2010 Oct; 29(172):247-9. PubMed ID: 21207641 [TBL] [Abstract][Full Text] [Related]
12. Osteoporosis in Turner's syndrome and other forms of primary amenorrhoea. Davies MC; Gulekli B; Jacobs HS Clin Endocrinol (Oxf); 1995 Dec; 43(6):741-6. PubMed ID: 8736278 [TBL] [Abstract][Full Text] [Related]
13. The effect of hormone replacement therapy on cardiovascular hemodynamics in women with Turner's syndrome. Elsheikh M; Bird R; Casadei B; Conway GS; Wass JA J Clin Endocrinol Metab; 2000 Feb; 85(2):614-8. PubMed ID: 10690864 [TBL] [Abstract][Full Text] [Related]
14. Normal DXA bone mineral density but frail cortical bone in Turner's syndrome. Zuckerman-Levin N; Yaniv I; Schwartz T; Guttmann H; Hochberg Z Clin Endocrinol (Oxf); 2007 Jul; 67(1):60-4. PubMed ID: 17437508 [TBL] [Abstract][Full Text] [Related]
15. Hyperlipidemia and presence of thyroid autoantibodies in girls with Turner's syndrome or mosaic variance. Mitsibounas DN; Kosmaidou Z; Kontoleon P; Deligeoroglou E; Liberatou E J Pediatr Adolesc Gynecol; 1997 Aug; 10(3):133-9. PubMed ID: 9288657 [TBL] [Abstract][Full Text] [Related]
16. [Effect of hormone replacement therapy on lipid metabolism in patients with premature ovarian failure and Turner's syndrome]. Yahata T; Kurabayashi T; Kato R; Yamamoto Y; Fujimaki T; Yasuda M; Oda K; Yoshizawa H; Tanaka K Nihon Sanka Fujinka Gakkai Zasshi; 1994 Nov; 46(11):1197-204. PubMed ID: 7844437 [TBL] [Abstract][Full Text] [Related]
18. Pituitary response to synthetic luteinizing hormone-releasing hormone in patients with Turner's syndrone. Huang KE J Clin Endocrinol Metab; 1975 Oct; 41(4):771-6. PubMed ID: 1100644 [TBL] [Abstract][Full Text] [Related]
19. Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiol. Gravholt CH; Naeraa RW; Fisker S; Christiansen JS J Clin Endocrinol Metab; 1997 Aug; 82(8):2570-7. PubMed ID: 9253336 [TBL] [Abstract][Full Text] [Related]
20. [Follow-up of adult women with Turner's syndrome in a cohort study in Utrecht]. Broekhuijsen-van Henten DM; de Vroede M Ned Tijdschr Geneeskd; 2007 Jul; 151(29):1630-4. PubMed ID: 17727185 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]